The role of immune checkpoint inhibitors in NSCLC
The role of immune checkpoint inhibitors in NSCLC
OncoAlert and ecancer weekly roundup for January 18 - 24, 2021
OncoAlert and ecancer weekly roundup for January 11 - 17, 2021
Updates on criteria for patient selection and surgical management in advanced ovarian cancer
Ferroptosis regulator as a novel therapeutic target for STK11/KEAP1 co-mutant lung adenocarcinoma
The biology and therapeutic options for STK11/KEAP1 co-mutant lung adenocarcinoma
The importance of Romanian oncology congress 2020
A young oncologist's perspective on advancing research in Romania
Why overall survival is still the gold standard end point
Latest in non-small cell lung cancer pathology
The Burkitt lymphoma international prognostic index
The use of PARP inhibitors in oncology from a palliative care perspective